Funding Mechanisms for Civil Society: The Experience of the AIDS Response
How resources are being used to fund the community response to human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) is of considerable interest to the donor community and governments. In the past decade, international f...
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Publication |
Language: | English en_US |
Published: |
Washington, DC: World Bank
2013
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/2013/01/17155962/funding-mechanisms-civil-society-experience-aids-response http://hdl.handle.net/10986/12231 |
Summary: | How resources are being used to fund the
community response to human immunodeficiency virus (HIV) and
acquired immune deficiency syndrome (AIDS) is of
considerable interest to the donor community and
governments. In the past decade, international funding for
the HIV and AIDS response provided by governments rose from
about US$1 billion to US$8.7 billion; donors increasingly
shifted their financial support toward funding community
responses to this epidemic. Yet little is known about the
global magnitude of these resource flows and how funding is
allocated among HIV and AIDS activities and services.
Although some studies have been carried out to gather
information on the community response by civil society
organizations (CSOs), most of them provide only partial
information limited to a specific intervention (for example,
orphan support) or specific local communities. To address
this knowledge gap, the report attempts to answer the
following questions: How large is donor funding for
community-based interventions that are run by either large
nongovernmental organizations (NGOs) or smaller
community-based organizations (CBOs)? How do the funds reach
various types of CSOs? What are CSOs' other sources of
funding, and to what extent are the CSOs dependent on donor
funding? How are these funds used for by CSOs? Are there
differences among different types of CSOs working on HIV and AIDS? |
---|